Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol in traumatic brain injury patients admitted to the ICU
2025-524194-17-00Phase 3Authorised
- Sponsor
- Hospital Universitari Son Espases
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in traumatic brain injury (TBI) comparing Propranolol with Placebo (2 arms). Primary endpoint: Hospital mortality. Planned start Feb 2026; status: authorised.
02
Drugs
propranolol
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on 2025-524194-17-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-524194-17-00.